Depression News

Suicide rates among American Indian or Alaska Native individuals increased nearly 20% from 2015 to 2020, compared with a less than 1% increase among the general American population, researchers reported in MMWR.

Researchers discovered evidence that meal timing has significant effects on anxiety- and depression-like mood levels, which were connected with internal circadian misalignment.

Autobahn Therapeutics announced it has received $32.7 million to advance clinical trials for ABX-002, a brain-boosting thyroid receptor beta agonist, to treat those with treatment-resistant depression.

Revitalist Lifestyle and Wellness and Wake Network Inc. announced a joint venture to offer ketamine infusions in the U.S. and psilocybin clinical retreats internationally with a special focus on military veterans’ need for access.

Parents of children with inflammatory bowel disease report relatively low rates of clinically significant psychological distress, even soon after their child’s IBD diagnosis, according to a cross-sectional study in Crohn’s & Colitis 360.

Children with type 1 diabetes have elevated risks for developing depression, anxiety and stress-related disorders, according to study data.

The FDA has granted breakthrough device designation to Magnus Medical for its neuromodulation treatment of major depressive disorder in adults who failed to achieve improvement from previously prescribed antidepressants.

Following the COVID-19 pandemic, the need for mental health care among all age groups is significantly prevalent, while the need for emergency psychiatrists continues to play a role in other aspects of the field.

The proportion of people with type 2 diabetes diagnosed with depression in the U.S. and U.K. increased from 2006 to 2017, particularly among those diagnosed with diabetes at a younger age, according to a study published in Diabetologia.

LAS VEGAS — Lesser-known cannabinoids are showing potential for treating neurological disease, inflammation, pain, cancer and infection, according to dermatologist Jeanette Jacknin, MD.